In-depth characterization of the phenotype of tumor-resident T cells revealed that, when compared with the CBD–IL-12 monotherapy, the dual therapy can regulate the immune cell fitness and lead to the decrease of terminally exhausted Toxhigh Lag3high Tim3high CD8+ T cell (32, 44, 45) population. Here, CD8A is linked to neoplasm.